These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


81 related items for PubMed ID: 9096603

  • 1. Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines.
    Diaz-Buxo JA, Blumenthal S, Hayes D, Gores P, Gordon B.
    Hepatology; 1997 Apr; 25(4):950-7. PubMed ID: 9096603
    [Abstract] [Full Text] [Related]

  • 2. An anesthetized model of lethal canine galactosamine fulminant hepatic failure.
    Sielaff TD, Hu MY, Rollins MD, Bloomer JR, Amiot B, Hu WS, Cerra FB.
    Hepatology; 1995 Mar; 21(3):796-804. PubMed ID: 7875678
    [Abstract] [Full Text] [Related]

  • 3. An improved model of galactosamine-induced fulminant hepatic failure in the pig.
    Kalpana K, Ong HS, Soo KC, Tan SY, Prema Raj J.
    J Surg Res; 1999 Apr; 82(2):121-30. PubMed ID: 10090819
    [Abstract] [Full Text] [Related]

  • 4. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis.
    Sielaff TD, Hu MY, Amiot B, Rollins MD, Rao S, McGuire B, Bloomer JR, Hu WS, Cerra FB.
    J Surg Res; 1995 Jul; 59(1):179-84. PubMed ID: 7630125
    [Abstract] [Full Text] [Related]

  • 5. D-galactosamine based canine acute liver failure model.
    Patzer JF, Block GD, Khanna A, Yin WY, Molmenti E, Gerber D, Kramer DJ, Scott VL, Aggarwal S, Wagner RA, Fulmer ML, Amiot BP, Mazariegos GV.
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):354-67. PubMed ID: 14607707
    [Abstract] [Full Text] [Related]

  • 6. Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality.
    Nakama T, Hirono S, Moriuchi A, Hasuike S, Nagata K, Hori T, Ido A, Hayashi K, Tsubouchi H.
    Hepatology; 2001 Jun; 33(6):1441-50. PubMed ID: 11391533
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Establishment of pig acute liver failure model and the role of pig fibrinogen-like protein 2].
    Guo JW, Xi D, Yan WM, Luo XP, Ning Q.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):691-4. PubMed ID: 19785959
    [Abstract] [Full Text] [Related]

  • 9. A model of fulminant hepatic failure in the rabbit.
    Blitzer BL, Waggoner JG, Jones EA, Gralnick HR, Towne D, Butler J, Weise V, Kopin IJ, Walters I, Teychenne PF, Goodman DG, Berk PD.
    Gastroenterology; 1978 Apr; 74(4):664-71. PubMed ID: 631503
    [Abstract] [Full Text] [Related]

  • 10. Water-soluble polysaccharide from Eleutherococcus senticosus stems attenuates fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
    Park EJ, Nan JX, Zhao YZ, Lee SH, Kim YH, Nam JB, Lee JJ, Sohn DH.
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):298-304. PubMed ID: 15228502
    [Abstract] [Full Text] [Related]

  • 11. Mao (Ephedra sinica Stapf) protects against D-galactosamine and lipopolysaccharide-induced hepatic failure.
    Yamada I, Goto T, Takeuchi S, Ohshima S, Yoneyama K, Shibuya T, Kataoka E, Segawa D, Sato W, Dohmen T, Anezaki Y, Ishii H, Ohnishi H.
    Cytokine; 2008 Mar; 41(3):293-301. PubMed ID: 18218321
    [Abstract] [Full Text] [Related]

  • 12. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis.
    Masubuchi Y, Horie T.
    Drug Metab Dispos; 2004 Apr; 32(4):437-41. PubMed ID: 15039297
    [Abstract] [Full Text] [Related]

  • 13. Galactosamine-induced fulminant hepatic failure.
    Nyberg SL.
    Hepatology; 1997 Nov; 26(5):1367-9. PubMed ID: 9362388
    [No Abstract] [Full Text] [Related]

  • 14. Large-animal models of fulminant hepatic failure.
    Takada Y, Ishiguro S, Fukunaga K.
    J Artif Organs; 2003 Nov; 6(1):9-13. PubMed ID: 14598118
    [Abstract] [Full Text] [Related]

  • 15. Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model.
    Arai K, Lee K, Berthiaume F, Tompkins RG, Yarmush ML.
    Hepatology; 2001 Aug; 34(2):360-71. PubMed ID: 11481621
    [Abstract] [Full Text] [Related]

  • 16. Animal models of fulminant hepatic failure: a critical evaluation.
    Newsome PN, Plevris JN, Nelson LJ, Hayes PC.
    Liver Transpl; 2000 Jan; 6(1):21-31. PubMed ID: 10648574
    [Abstract] [Full Text] [Related]

  • 17. A novel stable reproducible model of hepatic failure in canines.
    Awad SS, Hemmila MR, Soldes OS, Sawada S, Rich PB, Mahler S, Gargulinski M, Hirschl RB, Bartlett RH.
    J Surg Res; 2000 Dec; 94(2):167-71. PubMed ID: 11104657
    [Abstract] [Full Text] [Related]

  • 18. Change in liver and plasma ceramides during D-galactosamine-induced acute hepatic injury by LC-MS/MS.
    Yamaguchi M, Miyashita Y, Kumagai Y, Kojo S.
    Bioorg Med Chem Lett; 2004 Aug 02; 14(15):4061-4. PubMed ID: 15225726
    [Abstract] [Full Text] [Related]

  • 19. [Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome].
    Saracyn M, Wesołowski P, Nowak Z, Patera J, Kozłowski W, Wańkowicz Z.
    Pol Merkur Lekarski; 2008 Apr 02; 24(142):298-302. PubMed ID: 18634359
    [Abstract] [Full Text] [Related]

  • 20. The role of leukotriene D4 in septic shock models.
    Hartung T, Tiegs G, Wendel A.
    Eicosanoids; 1992 Apr 02; 5 Suppl():S42-4. PubMed ID: 1449830
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.